Form 8-K - Current report:
SEC Accession No. 0001193125-21-177785
Filing Date
2021-06-01
Accepted
2021-06-01 07:16:02
Documents
14
Period of Report
2021-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d16438d8k.htm   iXBRL 8-K 33134
2 EX-99.1 d16438dex991.htm EX-99.1 21116
6 GRAPHIC g16438g0601063358782.jpg GRAPHIC 2475
  Complete submission text file 0001193125-21-177785.txt   195942

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcyt-20210601.xsd EX-101.SCH 3068
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcyt-20210601_lab.xml EX-101.LAB 18886
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcyt-20210601_pre.xml EX-101.PRE 11858
7 EXTRACTED XBRL INSTANCE DOCUMENT d16438d8k_htm.xml XML 3483
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 21982940
SIC: 8071 Services-Medical Laboratories